Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia

Leukemia Research

Volumn 32, Issue 6, 2008, Pages 904-912

  Hou, Hsin An ^a   Chou, Wen Chien ^a   Lin, Liang In ^b   Tang, Jih Luh ^a   Tseng, Mei Hsuan ^a   Huang, Chi Fei ^a   Yao, Ming ^a   Chen, Chien Yuan ^a   Tsay, Woei ^a   Tien, Hwei Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acute myeloid leukemia; Angiopoietin; Survival; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CYTARABINE; DAUNORUBICIN; IDARUBICIN; VASCULOTROPIN A; VASCULOTROPIN C;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOGENETICS; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-1; ANGIOPOIETIN-2; BONE MARROW; COHORT STUDIES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, TIE-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 40849088142     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.08.010     Document Type: Article

References (43)

1. Risau W. Mechanisms of angiogenesis. Nature 386 6626 (1997) 671-674
2. Fiedler W., Staib P., Kuse R., et al. Role of angiogenesis inhibitors in acute myeloid leukaemia. Cancer J 7 Suppl. 3 (2001) S129-S133
3. Holash J., Wiegand S.J., and Yancopoulos G.D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18 38 (1999) 5356-5362
4. Hussong J.W., Rodgers G.M., and Shami P.J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95 1 (2000) 309-313
5. Padro T., Ruiz S., Bieker R., et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 95 8 (2000) 2637-2644
6. de Bont E.S., Rosati S., Jacobs S., Kamps W.A., and Vellenga E. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor. Br J Haematol 113 2 (2001) 296-304
7. Dickson D.J., and Shami P.J. Angiogenesis in acute and chronic leukemias. Leuk Lymphoma 42 5 (2001) 847-853
8. Moehler T.M., Ho A.D., Goldschmidt H., and Barlogie B. Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol 45 3 (2003) 227-244
9. Mangi M.H., and Newland A.C. Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol 111 1 (2000) 43-51
10. De Raeve H., Van Marck E., Van Camp B., and Vanderkerken K. Angiogenesis and the role of bone marrow endothelial cells in haematological malignancies. Histol Histopathol 19 3 (2004) 935-950
11. Holash J., Maisonpierre P.C., Compton D., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 5422 (1999) 1994-1998
12. Aguayo A., Estey E., Kantarjian H., et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 94 11 (1999) 3717-3721
13. Dias S., Choy M., Alitalo K., and Rafii S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 99 6 (2002) 2179-2184
14. Fiedler W., Graeven U., Ergun S., et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89 6 (1997) 1870-1875
15. Tait C.R., and Jones P.F. Angiopoietins in tumours: the angiogenic switch. J Pathol 204 1 (2004) 1-10
16. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., and Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res 86 1 (2000) 24-29
17. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 5322 (1997) 55-60
18. Lobov I.B., Brooks P.C., and Lang R.A. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 99 17 (2002) 11205-11210
19. Sfiligoi C., de Luca A., Cascone I., et al. Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 103 4 (2003) 466-474
20. Tanaka F., Ishikawa S., Yanagihara K., et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 62 23 (2002) 7124-7129
21. Etoh T., Inoue H., Tanaka S., Barnard G.F., Kitano S., and Mori M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61 5 (2001) 2145-2153
22. Loges S., Heil G., Bruweleit M., et al. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival. J Clin Oncol 23 6 (2005) 1109-1117
23. Chou W.C., Tang J.L., Yao M., et al. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment. Leukemia 11 7 (1997) 921-928
24. Chou W.C., Tang J.L., Wu S.J., et al. Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations. Leukemia 21 5 (2007) 998-1004
25. Hsu S.M., Raine L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29 4 (1981) 577-580
26. Lin L.I., Lin D.T., Chang C.J., Lee C.Y., Tang J.L., and Tien H.F. Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukaemia: potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia. Br J Haematol 117 4 (2002) 835-841
27. Tien H.F., Wang C.H., Lin M.T., et al. Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukaemia. A study of 235 Chinese patients in Taiwan. Cancer Genet Cytogenet 84 1 (1995) 60-68
28. Watarai M., Miwa H., Shikami M., et al. Expression of endothelial cell-associated molecules in AML cells. Leukemia 16 1 (2002) 112-119
29. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., and Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274 22 (1999) 15732-15739
30. Mandriota S.J., and Pepper M.S. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83 8 (1998) 852-859
31. Acker T., Beck H., and Plate K.H. Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularization. Mech Dev 108 1-2 (2001) 45-57
32. Vajkoczy P., Farhadi M., Gaumann A., et al. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 109 6 (2002) 777-785
33. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90 12 (2002) 1243-1250
34. Wakabayashi M., Miwa H., Shikami M., et al. Autocrine pathway of angiopoietins-Tie2 system in AML cells: association with phosphatidyl-inositol 3 kinase. Hematol J 5 4 (2004) 353-360
35. Xu Q., Simpson S.E., Scialla T.J., Bagg A., and Carroll M. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 102 3 (2003) 972-980
36. Min Y.H., Eom J.I., Cheong J.W., et al. Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable. Leukemia 17 5 (2003) 995-997
37. Arai F., Hirao A., Ohmura M., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 2 (2004) 149-161
38. Wulf G.G., Wang R.Y., Kuehnle I., et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 98 4 (2001) 1166-1173
39. Lee J.H., Koh J.T., Shin B.A., et al. Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer. Int J Oncol 18 2 (2001) 355-361
40. Chung Y.C., Hou Y.C., Chang C.N., and Hseu T.H. Expression and prognostic significance of angiopoietin in colorectal carcinoma. J Surg Oncol 94 7 (2006) 631-638
41. Maffei R., Marasca R., Martinelli S., et al. Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status. Leukemia (2007)
42. Schliemann C., Bieker R., Padro T., et al. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia. Haematologica 91 9 (2006) 1203-1211
43. Shih T.T., Tien H.F., Liu C.Y., Su W.P., Chan W.K., and Yang P.C. Functional MR imaging of tumor angiogenesis predicts outcome of patients with acute myeloid leukemia. Leukemia 20 2 (2006) 357-362